Columns (LC)
Bioseparation Solution: ProteoSil BioLC Column
Feb 13 2024
GL Sciences' Bio LC Columns “ProteoSil” are tailored HPLC solutions designed specifically for proteomics and the analysis of bio molecules such as proteins, peptides, and nucleic acids.
The packing materials used in these columns are crafted from high-purity silica, offering pore sizes of 100Å, 200Å, and 300Å. They are available in multiple configurations, including reversed phase, HILIC, and size exclusion columns. This versatility allows for a wide range of analytical possibilities.
One notable feature of the ProteoSil HPLC columns is their precise control over pore sizes in the packing material. The 200Å pore size is particularly optimized for the analysis of compounds with molecular weights ranging from a few kDa to several tens of kDa. This makes it perfect for the analysis of peptides and oligonucleotides, delivering exceptional performance in these applications.
Furthermore, users can choose between stainless steel and BioInert PEEK for the column hardware. The stainless-steel coated PEEK hardware design has enhanced the maximum operating pressure of the columns, providing greater flexibility in usage.
Quality and consistency are paramount, and GL Sciences ensures this by holding ISO 9001 and ISO 14001 certifications at their production facility. They oversee all processes, from matrix synthesis and chemical treatment to column packing and quality inspections, in-house. Their continuous evolution based on accumulated expertise guarantees the delivery of superior HPLC columns.
In addition to the mentioned features, GL Sciences offers chemical modification of functional groups, endcap processing, and the synthesis of silica gel, all critical components that contribute to exceptional column performance. With GL Sciences Bio LC Columns, researchers can rely on high-quality, globally accessible HPLC solutions for their bio molecule proteomics needs.
Events
Jan 20 2025 Amsterdam, Netherlands
Feb 03 2025 Dubai, UAE
Feb 05 2025 Guangzhou, China
Mar 01 2025 Boston, MA, USA
Mar 04 2025 Berlin, Germany